Literature DB >> 10793248

No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease.

M Baker1, D Graff-Radford, F Wavrant DeVrièze, N Graff-Radford, R C Petersen, E Kokmen, B Boeve, L Myllykangas, T Polvikoski, R Sulkava, A Verkoniemmi, P Tienari, M Haltia, J Hardy, M Hutton, J Perez-Tur.   

Abstract

We and others have previously identified two distinct haplotypes of the TAU gene in Caucasian populations. In this study, we have assessed whether these haplotypes show an association with Alzheimer's disease in a variety of populations. They do not. These data are consistent with the view that the involvement of TAU in Alzheimer's disease is a downstream event.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10793248     DOI： 10.1016/s0304-3940(00)01057-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN： 0304-3940            Impact factor:   3.046


  10 in total

1.  Differential incorporation of tau isoforms in Alzheimer's disease.

Authors:  Marisol Espinoza; Rohan de Silva; Dennis W Dickson; Peter Davies
Journal:  J Alzheimers Dis       Date:  2008-05       Impact factor: 4.472

2.  Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer's disease in a sample of Colombian patients.

Authors:  D A Forero; G Arboleda; J J Yunis; R Pardo; H Arboleda
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

3.  A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease.

Authors:  Chris Conrad; Cintia Vianna; Melissa Freeman; Peter Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.

Authors:  Odity Mukherjee; John S K Kauwe; Kevin Mayo; John C Morris; Alison M Goate
Journal:  BMC Genet       Date:  2007-01-31       Impact factor: 2.797

Review 5.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

Review 6.  Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

Authors:  Cheng-Cheng Zhang; Jun-Xia Zhu; Yu Wan; Lin Tan; Hui-Fu Wang; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2017-07-04

7.  Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy.

Authors:  Heike J Wobst; Franziska Denk; Peter L Oliver; Achilleas Livieratos; Tonya N Taylor; Maria H Knudsen; Nora Bengoa-Vergniory; David Bannerman; Richard Wade-Martins
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

8.  Primary age-related tauopathy in a Finnish population-based study of the oldest old (Vantaa 85+).

Authors:  Sara Savola; Karri Kaivola; Anna Raunio; Mia Kero; Mira Mäkelä; Kalle Pärn; Priit Palta; Maarit Tanskanen; Jarno Tuimala; Tuomo Polvikoski; Pentti J Tienari; Anders Paetau; Liisa Myllykangas
Journal:  Neuropathol Appl Neurobiol       Date:  2022-01-23       Impact factor: 6.250

Review 9.  Tau protein in familial and sporadic diseases.

Authors:  Despina Yancopoulou; Maria Grazia Spillantini
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

10.  MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.

Authors:  Samantha L Strickland; Joseph S Reddy; Mariet Allen; Aurelie N'songo; Jeremy D Burgess; Morgane M Corda; Travis Ballard; Xue Wang; Minerva M Carrasquillo; Joanna M Biernacka; Gregory D Jenkins; Shubhabrata Mukherjee; Kevin Boehme; Paul Crane; John S Kauwe; Nilüfer Ertekin-Taner
Journal:  Alzheimers Dement       Date:  2020-05-13       Impact factor: 16.655
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.